Skip to content

A Study on the Effect of Food Containing Plant Extract on Postprandial Serum Triglyceride -A Randomized, Double-blind, Placebo-controlled, Cross-over Study-

A Study on the Effect of Food Containing Plant Extract on Postprandial Serum Triglyceride -A Randomized, Double-blind, Placebo-controlled, Cross-over Study- - A Study on the Effect of Food Containing Plant Extract on Postprandial Serum Triglyceride

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000032218
Enrollment
90
Registered
2018-04-13
Start date
2018-04-14
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Sponsors

KSO Corporation
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Healthy males and females aged 20 to 64 years-old. (2) Subjects whose fasting serum triglyceride levels are under 150 mg/dL. (3) Subjects who can make self-judgment and are voluntarily giving written informed consent.

Exclusion criteria

Exclusion criteria: (1) Subjects who use oral medications affecting lipid metabolism. (2) Subjects who can't stop using supplements and/or functional foods (including Food for Specified Health Uses or Foods with Function Claims) affecting lipid metabolism during test periods. (3) Subjects who can't stop drinking from 2 days before each measurement. (4) Subjects who have declared allergic reaction to ingredients contained in test foods or high-fat diets. (5) Subjects who contract or are under treatment for serious diseases (e.g., kidney disease, heart disease, respiratory disease, endocrine disease, and/or metabolic disease). (6) Subjects who have a chronic disease and use medications continuously. (7) Subjects who have a history and/or a surgical history of digestive disease affecting digestion and absorption. (8) Subjects who are judged as unsuitable for the current study based on the results of screening tests by the investigator. (9) Subjects who are diagnosed as anemic and not suitable for frequent collection of blood. (10) Subjects who are prone to diarrhea. (11) Subjects who have donated over 200 mL of blood and/or blood components within the last one month prior to the current study or over 400 mL of blood and/or blood components within the last three months prior to the current study. (12) Subjects who have been diagnosed as familial hyperlipidemia. (13) Subjects who are under treatment for or have a history of drug addiction and/or alcoholism. (14) Subjects who are planning to participate and/or have participated in other clinical studies within the last one month prior to the current study. (15) Subjects who are planning to become pregnant after informed consent for the current study, pregnant or lactating. (16) Subjects who are judged as unsuitable for the current study by the investigator for other reasons.

Design outcomes

Primary

MeasureTime frame
Serum triglyceride AUC

Countries

Japan

Contacts

Public ContactYoshika Komori

KSO Corporation Sales department

yoshi@kso.co.jp03-3452-7733

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026